Plasma level of Amyloid β42 Is independent of neuronal function in Alzheimer's Disease

Plasma level of Amyloid β42 Is independent of neuronal function in Alzheimer's Disease

Bibliographic Details
Main Authors:	Dimitriadis Athanasios S, Dedousi Eleni, Costa Vassiliki, Gotzamani-Psarrakou Anna, Sedaghat Fereshteh, Baloyannis Stavros J
Format:	Article
Language:	English
Published:	BMC 2008-04-01
Series:	Annals of General Psychiatry

Similar Items

The contribution of brain perfusion SPECT and magnetic resonance imaging in early diagnosis of neurodegenerative dementia
by: Baloyannis Stavros J, et al.
Published: (2008-04-01)

Right inferior parietal region hypoperfusion as a reflection of anosognosia in dementia
by: Dimitriadis Athanasios S, et al.
Published: (2008-04-01)

In vitro fibrillization of Alzheimer’s amyloid-β peptide (1-42)
by: Ann Tiiman, et al.
Published: (2015-09-01)

Apraxia Patterns for the Differentiation between Alzheimer’s Disease and Frontotemporal Dementia Variants
by: Georgios Papadopoulos, et al.
Published: (2024-03-01)

Derivation of cutoffs for the Elecsys® amyloid β (1–42) assay in Alzheimer's disease
by: Leslie M. Shaw, et al.
Published: (2018-01-01)

Is plasma amyloid-β 1–42/1–40 a better biomarker for Alzheimer’s disease than AβX–42/X–40?
by: Hans-Wolfgang Klafki, et al.
Published: (2022-12-01)

Oligomer Formation by Amyloid-β42 in a Membrane-Mimicking Environment in Alzheimer’s Disease
by: Terrone L. Rosenberry, et al.
Published: (2022-12-01)

Influence of Hyperglycemic Conditions on Self-Association of the Alzheimer’s Amyloid β (Aβ1–42) Peptide
by: Sneha Menon, et al.
Published: (2017-05-01)

Staining neurons with Golgi techniques in degenerative diseases of the brain
by: Stavros J Baloyannis
Published: (2015-01-01)

Paper-Based Detection Device for Alzheimer’s Disease—Detecting β-amyloid Peptides (1–42) in Human Plasma
by: Wei-Hsuan Sung, et al.
Published: (2020-04-01)

Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease
by: Oskar Hansson, et al.
Published: (2019-04-01)

Memantine protects the cultured rat hippocampal neurons treated by NMDA and amyloid β1–42
by: Nataliia M. Rozumna, et al.
Published: (2023-12-01)

Plasma amyloid β 42/40 ratios as biomarkers for amyloid β cerebral deposition in cognitively normal individuals
by: Noelia Fandos, et al.
Published: (2017-01-01)

Different associations between amyloid-βeta 42, amyloid-βeta 40, and amyloid-βeta 42/40 with soluble phosphorylated-tau and disease burden in Alzheimer’s disease: a cerebrospinal fluid and fluorodeoxyglucose-positron emission tomography study
by: Caterina Motta, et al.
Published: (2023-08-01)

Microarray analysis on human neuroblastoma cells exposed to aluminum, β(1-42)-amyloid or the β(1-42)-amyloid aluminum complex.
by: Valentina Gatta, et al.
Published: (2011-01-01)

Neuronal ER-Signalosome Proteins as Early Biomarkers in Prodromal Alzheimer's Disease Independent of Amyloid-β Production and Tau Phosphorylation
by: Fátima Mesa-Herrera, et al.
Published: (2022-05-01)

Metabolites of soil microorganisms modulate amyloid β production in Alzheimer’s neurons
by: Takayuki Kondo, et al.
Published: (2022-03-01)

Cerebrospinal fluid β-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain
by: Tapiola, T, et al.
Published: (2009)

Unveiling amyloid-β1–42 interaction with zinc in water and mixed hexafluoroisopropanol solution in Alzheimer’s disease
by: Ghani, Nur Syafiqah Abdul, et al.
Published: (2017)

Cellular Prion Protein as a Receptor of Toxic Amyloid-β42 Oligomers Is Important for Alzheimer’s Disease
by: Yuan Zhang, et al.
Published: (2019-07-01)

Influence of denaturants on amyloid β42 aggregation kinetics
by: Tanja Weiffert, et al.
Published: (2022-09-01)

Characteristics of discordance between amyloid positron emission tomography and plasma amyloid-β 42/40 positivity
by: Jung-Min Pyun, et al.
Published: (2024-02-01)

Facilitation of Gastrointestinal (GI) Tract Microbiome-Derived Lipopolysaccharide (LPS) Entry Into Human Neurons by Amyloid Beta-42 (Aβ42) Peptide
by: Walter J. Lukiw, et al.
Published: (2019-12-01)

Mechanism Exploration of Amyloid-β-42 Disaggregation by Single-Chain Variable Fragments of Alzheimer’s Disease Therapeutic Antibodies
by: Xing Fan, et al.
Published: (2023-05-01)

The synergy of β amyloid 1-42 and oxidative stress in the development of Alzheimer’s disease-like neurodegeneration of hippocampal cells
by: Gohar Karapetyan, et al.
Published: (2022-10-01)

β-Amyloid (1–42) Levels in Cerebrospinal Fluid and Cerebral Atrophy in Mild Cognitive Impairment and Alzheimer’s Disease
by: Elmar Kaiser, et al.
Published: (2011-11-01)

The Relevance of Amyloid β-Calmodulin Complexation in Neurons and Brain Degeneration in Alzheimer’s Disease
by: Joana Poejo, et al.
Published: (2021-05-01)

Neuronal Rubicon Represses Extracellular APP/Amyloid β Deposition in Alzheimer’s Disease
by: Sandra Espinoza, et al.
Published: (2022-06-01)

Key Residues for the Formation of Aβ42 Amyloid Fibrils
by: Frederick Hsu, et al.
Published: (2018-07-01)

Revisiting Cu(II) Bound Amyloid-β40 and Amyloid-β42 Peptides: Varying Coordination Chemistries
by: Orkid Coşkuner-Weber
Published: (2018-08-01)

Type 2 diabetes mellitus and cerebrospinal fluid Alzheimer's disease biomarker amyloid β1‐42 in Alzheimer's Disease Neuroimaging Initiative participants
by: Wei Li, et al.
Published: (2018-01-01)

Cerebrospinal fluid β-amyloid1-42 levels in the differential diagnosis of Alzheimer's disease--systematic review and meta-analysis.
by: Jin-A Mo, et al.
Published: (2015-01-01)

A β-Amyloid(1-42) Biosensor Based on Molecularly Imprinted Poly-Pyrrole for Early Diagnosis of Alzheimer’s Disease
by: Rezvan Dehdari Vais, et al.
Published: (2021-04-01)

The Alzheimer’s Disease γ-Secretase Generates Higher 42:40 Ratios for β-Amyloid Than for p3 Peptides
by: Gabriele Siegel, et al.
Published: (2017-06-01)

Predicting continuous amyloid PET values with CSF and plasma Aβ42/Aβ40
by: Julie K. Wisch, et al.
Published: (2023-01-01)

Dynamic changes of oligomeric amyloid β levels in plasma induced by spiked synthetic Aβ42
by: Seong Soo A. An, et al.
Published: (2017-10-01)

secHsp70 as a tool to approach amyloid-β42 and other extracellular amyloids
by: Lorena De Mena, et al.
Published: (2017-07-01)

Neuronal MHC-I complex is destabilized by amyloid-β and its implications in Alzheimer’s disease
by: Min-Seok Kim, et al.
Published: (2023-09-01)

Amyloid-Independent Mechanisms in Alzheimer's Disease Pathogenesis
by: Pimplikar, Sanjay W., et al.
Published: (2015)

Β-amyloid 1-42 oligomers impair function of human embryonic stem cell-derived forebrain cholinergic neurons.
by: Linn Wicklund, et al.
Published: (2010-12-01)